Trash or treasure? Unlocking dark matter of enantiomeric natural products in innovative drugs discovery for potent angiogenesis inhibitors

Yan-Wei Wu , Xiao-Feng Mou , Zhong-Yuan Chen , Xiao-Jia Xue , Wen-Hui Wang , Jin-Zhou Guo , Bo-Qi Zhang , Ting-Ting Xue , Qun Zhang , Mei-Yan Wei , Yu-Cheng Gu , Gulab Said , Chang-Yun Wang , Ling Lu , Chang-Lun Shao

Marine Life Science & Technology ›› : 1 -16.

PDF
Marine Life Science & Technology ›› :1 -16. DOI: 10.1007/s42995-025-00307-8
Research Paper
research-article

Trash or treasure? Unlocking dark matter of enantiomeric natural products in innovative drugs discovery for potent angiogenesis inhibitors

Author information +
History +
PDF

Abstract

The occurrence and development of tumors rely on the nutritional supply from blood vessels, which also serve as the main pathway for tumor metastasis. Inhibiting angiogenesis is one of the main strategies for cancer treatments. Chiral drugs, encouraged and inspired by chiral natural products, make up a major portion of marketed drugs. However, as an important source for synthetic chemistry and drug discovery, the counterpart of chiral natural products, the enantiomers, has received little attention. Here, we constructed a compound library containing 100 racemates ( ±)-1100 and 4 pairs of enantiomers (33, 48, 59, 68) of 3,4-dioxygenated-4-aryl-quinolin-2(1H)-one alkaloids. Through extensive activity screening, we found that the compounds with 3R, 4R configuration, opposite to the natural products, exhibited potent angiogenesis inhibitory activity in zebrafish, while the 3S, 4S-configured natural derivatives have no effects. More importantly, compound ( +)-48, named as (3R, 4R)-CHNQD-00728, significantly inhibited hepatic tumor growth in doxycin hydrochloride-induced liver-specific enlargement zebrafish. Examining the phenomenon and unlocking dark matter of enantiomeric natural products in innovative drugs discovery can provide a new perspective on organic synthesis and medicinal chemistry, thus enabling a broader exploration.

Keywords

Angiogenesis / Chirality / Chiral natural products / Enantiomers / Dark matter of enantiomeric natural products / Innovative drugs

Cite this article

Download citation ▾
Yan-Wei Wu, Xiao-Feng Mou, Zhong-Yuan Chen, Xiao-Jia Xue, Wen-Hui Wang, Jin-Zhou Guo, Bo-Qi Zhang, Ting-Ting Xue, Qun Zhang, Mei-Yan Wei, Yu-Cheng Gu, Gulab Said, Chang-Yun Wang, Ling Lu, Chang-Lun Shao. Trash or treasure? Unlocking dark matter of enantiomeric natural products in innovative drugs discovery for potent angiogenesis inhibitors. Marine Life Science & Technology 1-16 DOI:10.1007/s42995-025-00307-8

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

AhrendtKA, BorthsCJ, MacMillanDWC. New strategies for organic catalysis: the first highly enantioselective organocatalytic Diels-Alder reaction. J Am Chem Soc, 2000, 122: 4243-4244

[2]

AnC-Y, LiX-M, LiC-S, WangM-H, XuG-M, WangB-G. Aniquinazolines A–D, four new quinazolinone alkaloids from marine-derived endophytic fungus Aspergillus nidulans. Mar Drugs, 2013, 11: 2682-2694

[3]

AnC-Y, LiX-M, LuoH, LiC-S, WangM-H, XuG-M, WangB-G. 4-Phenyl-3,4-dihydroquinolone derivatives from Aspergillus nidulans MA-143, an endophytic fungus isolated from the mangrove plant Rhizophora stylosa. J Nat Prod, 2013, 76: 1896-1901

[4]

AtanasovAG, ZotchevSB, DirschVM, SupuranCT. Natural products in drug discovery: advances and opportunities. Nat Rev Drug Discov, 2021, 20: 200-216

[5]

AzevedoT, FerreiraT, Peña-CoronaSI, CortesH, Silva-ReisR, da CostaRMG, Faustino-RochaAI, OliveiraPA, CalinaD, CardosoSM, BüsselbergD, Leyva-GómezG, Sharifi-RadJ, ChoWC. Natural products-based antiangiogenic agents: new frontiers in cancer therapy. Food Front, 2024, 5: 2423-2466

[6]

BitchagnoGTM, Nchiozem-NgnitedemV-A, MelchertD, FobofouSA. Demystifying racemic natural products in the homochiral world. Nat Rev Chem, 2022, 6: 806-822

[7]

BrandtJR, SalernoF, FuchterMJ. The added value of small-molecule chirality in technological applications. Nat Rev Chem, 2017, 10045

[8]

BrooksWH, GuidaWC, DanielKG. The significance of chirality in drug design and development. Curr Top Med Chem, 2011, 11: 760-770

[9]

CaoY, LangerR, FerraraN. Targeting angiogenesis in oncology, ophthalmology and beyond. Nat Rev Drug Discov, 2023, 22: 476-495

[10]

CarmelietP. Angiogenesis in life, disease and medicine. Nature, 2005, 438: 932-936

[11]

CarmelietP, JainRK. Molecular mechanisms and clinical applications of angiogenesis. Nature, 2011, 473: 298-307

[12]

CarrollAR, CoppBR, GrkovicT, KeyzersRA, PrinsepMR. Marine natural products. Nat Prod Rep, 2024, 41: 162-207

[13]

ChenM, ShaoC-L, MengH, SheZ-G, WangC-Y. Anti-respiratory syncytial virus prenylated dihydroquinolone derivatives from the gorgonian-derived fungus Aspergillus sp. XS-20090B15. J Nat Prod, 2014, 77: 2720-2724

[14]

ChenJ, XuL, ZhangX-Q, LiuX, ZhangZ-X, ZhuQ-M, LiuJ-Y, IqbalMO, DingN, ShaoC-L, WeiM-Y, GuY-C. Discovery of a natural small-molecule AMP-activated kinase activator that alleviates nonalcoholic steatohepatitis. Mar Life Sci Technol, 2023, 5: 196-210

[15]

CrossLM, CookMA, ChenSLJ-N, RubinsteinAL. Rapid analysis of angiogenesis drugs in a live fluorescent zebrafish assay. Arterioscl Throm Vas, 2003, 23: 911-912

[16]

DaiC, LiX, ZhangK, LiX-N, WangW, ZangY, ChenX, LiQ, WeiM, ChenC, ZhuH, ZhangY. Pesimquinolones I–S, eleven new quinolone alkaloids produced by Penicillium simplicissimum and their inhibitory activity on NO production. Bioorg Chem, 2021, 108104635

[17]

DudleyAC, GriffioenAW. The modes of angiogenesis: an updated perspective. Angiogenesis, 2023, 26: 477-480

[18]

El-KashefDH, DaletosG, PlenkerM, HartmannR, MándiA, KurtánT, WeberH, LinW, AncheevaE, ProkschP. Polyketides and a dihydroquinolone alkaloid from a marine-derived strain of the fungus Metarhizium marquandii. J Nat Prod, 2019, 82: 2460-2469

[19]

FerraraN, KerbelRS. Angiogenesis as a therapeutic target. Nature, 2005, 438: 967-974

[20]

FolkmanJ. Tumor angiogenesis: therapeutic implications. New Engl J Med, 1971, 285: 1182-1186

[21]

FolkmanJ. Angiogenesis: an organizing principle for drug discovery?. Nat Rev Drug Discov, 2007, 6: 273-286

[22]

GuoF-W, MouX-F, QuY, WeiM-Y, ChenG-Y, WangC-Y, GuY-C, ShaoC-L. Scalable total synthesis of (+)-aniduquinolone A and its acid-catalyzed rearrangement to aflaquinolones. Commun Chem, 2022, 535

[23]

GuoF-W, GaoY, GuY-C, ShaoC-L. Scalable total synthesis of aflaquinolone I and confirmation of the absolute configuration. Tetrahedron, 2023, 13413299

[24]

GuoF-W, ZhouT-Y, QuY, WeiM-Y, ChenG-Y, GuY-C, WangC-Y, ShaoC-L. Highly efficient and scalable total syntheses and stereochemical assignment of potent anti-inflammatory pesimquinolones I and J. Org Chem Front, 2023, 10: 852-858

[25]

HanY-Q, ZhangQ, XuW-F, HaiY, ChaoR, WangC-F, HouX-M, WeiM-Y, GuY-C, WangC-Y, ShaoC-L. Targeted isolation of antitubercular cycloheptapeptides and an unusual pyrroloindoline-containing new analog, asperpyrroindotide A, using LC-MS/MS-based molecular networking. Mar Life Sci Technol, 2023, 5: 85-93

[26]

HanahanD, FolkmanJ. Patterns and emerging mechanisms review of the angiogenic switch during tumorigenesis. Cell, 1996, 86: 353-364

[27]

HayashiH, NakataniT, InoueY, NakayamaM, NozakiH. New dihydroquinolinone toxic to Artemia salina produced by Penicillium sp. NTC-47. Biosci Biotech Biochem, 1997, 61: 914-916

[28]

HeJ, LionU, SattlerI, GollmickAF, GrableyS, CaiJ, MeinersM, SchünkeH, SchaumannK, DechertU, KrohnM. Diastereomeric quinolinone alkaloids from the marine-derived fungus Penicillium janczewskii. J Nat Prod, 2005, 68: 1397-1399

[29]

HouX-M, LiangT-M, GuoZ-Y, WangC-Y, ShaoC-L. Discovery, absolute assignments, and total synthesis of asperversiamides A–C and their potent activity against Mycobacterium marinum. Chem Commun, 2019, 55: 1104-1107

[30]

HuZ, ZhuY, ChenJ, ChenJ, LiC, GaoZ, LiJ, LiuL. Discovery of novel bactericides from Aspergillus alabamensis and their antibacterial activity against fish pathogens. J Agric Food Chem, 2023, 71: 4298-4305

[31]

IshikawaN, TanakaH, KoyamaF, NoguchiH, WangCCC, HottaK, WatanabeK. Non-heme dioxygenase catalyzes atypical oxidations of 6,7-bicyclic systems to form the 6,6-quinolone core of viridicatin-type fungal alkaloids. Angew Chem, 2014, 126: 13094-13098

[32]

JangH-Y, HongJ-B, MacMillanDWC. Enantioselective organocatalytic singly occupied molecular orbital activation: the enantioselective r-enolation of aldehydes. J Am Chem Soc, 2007, 129: 7004-7005

[33]

JiaY-L, WeiM-Y, ChenH-Y, GuanF-F, WangC-Y, ShaoC-L. (+)- and (−)-Pestaloxazine A, a pair of antiviral enantiomeric alkaloid dimers with a symmetric spiro[oxazinane-piperazinedione] skeleton from Pestalotiopsis sp. Org Lett, 2015, 17: 4216-4219

[34]

JiaW-L, CesSV, Fernández-Ibáñez. Divergent total syntheses of yaequinolone-related natural products by late-stage C-H olefination. J Org Chem, 2021, 86: 6259-6277

[35]

JiangY-Y, GaoY, LiuJ-Y, XuY, WeiM-Y, WangC-Y, GuY-C, ShaoC-L. Design and characterization of a natural Arf-GEFs inhibitor prodrug CHNQD-01255 with potent anti-hepatocellular carcinoma efficacy in vivo. J Med Chem, 2022, 65: 11970-11984

[36]

KangJ-Q, ZhouT-Y, WangW-H, WeiM-Y, ShaoC-L. Marine-derived yaequinolone derivative CHNQD-02792 suppresses colorectal cancer cell proliferation and induces apoptosis via MAPK pathway modulation. Mar Drugs, 2025, 23136

[37]

KimuraY, KusanoM, KoshinoH, UzawaJ, FujiokaS, TaniK. Penigequinolones A and B, pollen-growth inhibitors produced by Penicillium sp., No. 410. Tetrahedron Lett, 1996, 37: 4961-4964

[38]

KusanoM, KoshinoH, UzawaJ, FujiokaS, KawanoT, KimuraY. Nematicidal alkaloids and related compounds produced by the fungus Penicillium cf. simplicissimum. Biosci Biotechnol Biochem, 2000, 64: 2559-2568

[39]

LiX, HuoX, LiJ, SheX, PanX. A concise synthesis of (±)-yaequinolone A2. Chinese J Chem, 2009, 27: 1379-1381

[40]

LiR, SongX, GuoY, SongP, DuanD, ChenZ-S. Natural products: a promising therapeutics for targeting tumor angiogenesis. Front Oncol, 2021, 11772915

[41]

LiuY, WuZ, ArmstrongDW, WoloskerH, ZhengY. Detection and analysis of chiral molecules as disease biomarkers. Nat Rev Chem, 2023, 7: 355-373

[42]

LiuZ-L, ChenH-H, ZhengL-L, SunL-P, ShiL. Angiogenic signaling pathways and anti-angiogenic therapy for cancer. Sig Transduct Target Ther, 2023, 8198

[43]

LiuJ-Y, JiangY-Y, LiP-J, YaoB, SongY-J, GaoJ-X, SaidG, GaoY, LaiJ-Y, ShaoC-L. Discovery of a potential bladder cancer inhibitor CHNQD-01281 by regulating EGFR and promoting infiltration of cytotoxic T cells. Mar Life Sci Technol, 2024, 6: 502-514

[44]

MajiR, GhoshS, GrossmannO, ZhangP, LeutzschM, TsujiN, ListB. A catalytic asymmetric hydrolactonization. J Am Chem Soc, 2023, 145: 8788-8793

[45]

MasoudGN, LiW. HIF-1α pathway: role, regulation and intervention for cancer therapy. Acta Pharm Sin B, 2015, 5: 378-389

[46]

McGrathNA, BrichacekM, NjardarsonJT. A graphical journey of innovative organic architectures that have improved our lives. J Chem Ed, 2010, 87: 1348-1349

[47]

McVickerRU, O’BoyleNM. Chirality of new srug approvals (2013–2022): trends and perspectives. J Med Chem, 2024, 67: 2305-2320

[48]

MouX-F, LiuX, XuR-F, WeiM-Y, FangY-W, ShaoC-L. Scopuquinolone B, a new monoterpenoid dihydroquinolin-2(1H)-one isolated from the coral-derived Scopulariopsis sp. fungus. Nat Prod Res, 2017, 32: 773-776

[49]

MullowneyMW, DuncanKR, ElsayedSS, GargN, van der HooftJJJ, MartinNI, MeijerD, TerlouwBR, BiermannF, BlinK, DurairajJ, Gorostiola GonzálezM, HelfrichEJN, HuberF, Leopold-MesserS, RajanK, de RondT, van SantenJA, SorokinaM, BalunasMJ, et al.. Artificial intelligence for natural product drug discovery. Nat Rev Drug Discov, 2023, 22: 895-916

[50]

NakayaT. Anti-brine shrimp substances produced by Penicillium sp. NTC-47. Seikatsu Eisei, 1995, 39: 141-143

[51]

NeffSA, LeeSU, AsamiY, AhnJS, OhH, BaltrusaitisJ, GloerJB, WicklowDT. Aflaquinolones A−G: secondary metabolites from marine and fungicolous isolates of Aspergillus spp. J Nat Prod, 2012, 75: 464-472

[52]

NewmanDJ, CraggGM. Natural products as sources of new drugs over the nearly four decades from 01/1981 to 09/2019. J Nat Prod, 2020, 83: 770-803

[53]

NewmanDJ. Natural products and drug discovery. Natl Sci Rev, 2022, 9nwac206

[54]

NguyenAT, EmelyanovA, KohCHV, SpitsbergenJM, ParinovS, GongZ. An inducible krasV12 transgenic zebrafish model for liver tumorigenesis and chemical drug screening. Dis Models Mech, 2012, 5: 63-72

[55]

NicolaouKC. The emergence of the structure of the molecule and the art of its synthesis. Angew Chem Int Edit, 2012, 52: 131-146

[56]

NicolaouKC, VourloumisD, WinssingerN, BaranPS. The art and science of total synthesis at the dawn of the twenty-first century. Angew Chem Int Edit, 2000, 39: 44-122

[57]

NiuX, ZhaoR, YanS, PangZ, LiH, YangX, WangK. Chiral materials: progress, applications, and prospects. Small, 2023, 192303059

[58]

PalazonA, TyrakisPA, MaciasD, VeliçaP, RundqvistH, FitzpatrickS, VojnovicN, PhanAT, LomanN, HedenfalkI, HatschekT, LövrotJ, FoukakisT, GoldrathAW, BerghJ, JohnsonRS. An HIF-1α/VEGF-A axis in cytotoxic T cells regulates tumor progression. Cancer Cell, 2017, 32: 669-683

[59]

ProkopiouEM, RyderSA, WalshJJ. Tumour vasculature targeting agents in hybrid/conjugate drugs. Angiogenesis, 2013, 16: 503-524

[60]

QuY, ZhouT-Y, GuoF-W, WeiM-Y, ChenG-Y, GuY-C, WangC-Y, ShaoC-L. Analogues of natural products yaequinolones as potential inflammatory inhibitors: design, synthesis and biological evaluation. Eur J Med Chem, 2023, 250115183

[61]

ScherlachK, HertweckC. Discovery of aspoquinolones A−D, prenylated quinoline-2-one alkaloids from Aspergillus nidulans, motivated by genome mining. Org Biomol Chem, 2006, 4: 3517-3520

[62]

Schmeda-HirschmannG, HormazabalE, AstudilloL, RodriguezJ, TheodulozC. Secondary metabolites from endophytic fungi isolated from the Chilean gymnosperm Prumnopitys andina (Lleuque). World J Microb Biot, 2005, 21: 27-32

[63]

SchwanJ, KleoffM, HartmayerB, HeretschP, ChristmannM. Synthesis of quinolinone alkaloids via aryne insertions into unsymmetric imides in flow. Org Lett, 2018, 20: 7661-7664

[64]

SchwanJ, KleoffM, HeretschP, ChristmannM. Five-step synthesis of yaequinolones J1 and J2. Org Lett, 2020, 22: 675-678

[65]

ShaoC-L, XuR-F, WangC-Y, QianP-Y, WangK-L, WeiM-Y. Potent antifouling marine dihydroquinolin-2(1H)-one-containing alkaloids from the gorgonian coral-derived fungus Scopulariopsis sp. Mar Biotechnol, 2015, 17: 408-415

[66]

Shao C-L, Wang C-Y, Mou X-F, Xu R-F (2020) U.S. Patent 10639303 B2, May 5.

[67]

ShenQ, WangL, ZhouH, JiangH-d, YuL-s, ZengS. Stereoselective binding of chiral drugs to plasma proteins. Acta Pharmacol Sin, 2013, 34: 998-1006

[68]

SimonettiSO, LarghiEL, KaufmanTS. The 3,4-dioxygenated 5-hydroxy-4-aryl-quinolin-2(1H)-one alkaloids. Results of 20 years of research, uncovering a new family of natural products. Nat Prod Rep, 2016, 33: 1425-1446

[69]

SimonettiSO, LarghiEL, KaufmanTS. A convenient approach to an advanced intermediate toward the naturally occurring, bioactive 6-substituted 5-hydroxy-4-aryl-1H-quinolin-2-ones. Org Biomol Chem, 2016, 14: 2625-2636

[70]

UchidaR, ImasatoR, YamaguchiY, MasumaR, ShiomiK, TomodaH, TomodaH, OmuraS. Yaequinolones, new insecticidal antibiotics produced by Penicillium sp. FKI-2140. J Antibiot, 2006, 59: 646-651

[71]

UchidaR, ImasatoR, YamaguchiY, MasumaR, ShiomiK, TomodaH, ŌmuraS. Yaequinolones, new insecticidal antibiotics produced by Penicillium sp. FKI-2140 I. Taxonomy, fermentation, isolation and biological activity. J Antibiot, 2006, 59: 652-658

[72]

UekiH, EllisTK, KhanMA, SoloshonokVA. Highly diastereoselective synthesis of new, carbostyril-based type of conformationally-constrained β-phenylserines. Tetrahedron, 2003, 59: 7301-7306

[73]

VafopoulouP, KourtiM. Anti-angiogenic drugs in cancer therapeutics: a review of the latest preclinical and clinical studies of anti-angiogenic agents with anticancer potential. J Cancer Metas Treat, 2022, 818

[74]

VeceV, JakkepallyS, HanessianS. Total synthesis and absolute stereochemical assignment of the insecticidal metabolites yaequinolones J1 and J2. Org Lett, 2018, 20: 4277-4280

[75]

WangJ, DiscordiaRP, CrispinoGA, LiJ, GrossoJA, PolniaszekR, TrucVC. A mild and efficient synthesis of 4-aryl-quinolin-2(1H)-ones via a tandem amidation/Knoevenagel condensation of 2-amino-benzophenones with esters or lactones. Tetrahedron Lett, 2003, 44: 4271-4273

[76]

WeidemannA, JohnsonRS. Biology of HIF-1α. Cell Death Differ, 2008, 15: 621-627

[77]

WeisSM, ChereshDA. Tumor angiogenesis: molecular pathways and therapeutic targets. Nat Med, 2011, 17: 1359-1370

[78]

WubshetSG, NybergNT, TejesviMV, PirttiläAM, KajulaM, MattilaS, StaerkD. Targeting high-performance liquid chromatography-high-resolution mass spectrometry-solid-phase extraction-nuclear magnetic resonance analysis with high-resolution radical scavenging profiles-bioactive secondary metabolites from the endophytic fungus Penicillium namyslowskii. J Chromatogr A, 2013, 1302: 34-39

[79]

XuW-F, ChaoR, HaiY, GuoY-Y, WeiM-Y, WangC-Y, ShaoC-L. 17-Hydroxybrevianamide N and its N1-methyl derivative, quinazolinones from a soft-coral-derived Aspergillus sp. fungus: 13S enantiomers as the true natural products. J Nat Prod, 2021, 84: 1353-1358

[80]

XuW-F, WuN-N, WuY-W, QiY-X, WeiM-Y, PinedaLM, NgMG, SpadaforaC, ZhengJ-Y, LuL, WangC-Y, GuY-C, ShaoC-L. Structure modification, antialgal, antiplasmodial, and toxic evaluations of a series of new marine-derived 14-membered resorcylic acid lactone derivatives. Mar Life Sci Technol, 2021, 4: 88-97

[81]

XuL, GuoF-W, ZhangX-Q, ZhouT-Y, WangC-J, WeiM-Y, GuY-C, WangC-Y, ShaoC-L. Discovery, total syntheses and potent anti-inflammatory activity of pyrrolinone-fused benzoazepine alkaloids asperazepanones A and B from Aspergillus candidus. Commun Chem, 2022, 580

[82]

ZhangQ, LvL-X, WangW-H, WeiM-Y, GuY-C, ShaoC-L. Recent advances of bioactive marine natural products in drug discovery. J Ocean Univ China, 2024, 23: 1297-1318

[83]

ZhaoY, XingC, DengY, YeC, PengH. HIF-1α signaling: essential roles in tumorigenesis and implications in targeted therapies. Genes Dis, 2024, 11: 234-251

[84]

ZouY, ZhanZ, LiD, TangM, CachoRA, WatanabeK, TangY. Tandem prenyltransferases catalyze isoprenoid elongation and complexity generation in biosynthesis of quinolone alkaloids. J Am Chem Soc, 2015, 137: 4980-4983

RIGHTS & PERMISSIONS

The Author(s)

PDF

89

Accesses

0

Citation

Detail

Sections
Recommended

/